DistantNews
Support us
'Mi Farma Digital' platform in Panama exceeds 150,000 visits in 36 hours
๐Ÿ‡ต๐Ÿ‡ฆ Panama /Technology

'Mi Farma Digital' platform in Panama exceeds 150,000 visits in 36 hours

From TVN Panamรก · () Spanish

Translated from Spanish, summarized and contextualized by DistantNews.

At a glance

News Official statement New plan
  • Panama's Social Security Fund (CSS) reported that its 'Mi Farma Digital' platform received over 150,000 visits in its first 36 hours.
  • The digital tool allows insured individuals to check medication availability at CSS pharmacies via the internet, aiming to reduce wait times and unnecessary travel.
  • Users have positively reviewed the platform's modernization efforts on social media, though some noted the need for continuous updates and adaptation.

Panama's Social Security Fund (CSS) announced that its new 'Mi Farma Digital' platform garnered over 150,000 visits within its initial 36 hours of operation. This digital tool empowers insured individuals to check medication availability at various CSS pharmacies using any internet-connected device.

The high demand highlights users' interest in a convenient way to find their treatments and confirm where they can pick them up. The platform aims to significantly reduce patient wait times, prevent unnecessary trips to pharmacies, and improve access to crucial information about medication stock within the institution's facilities.

Social media reactions to the CSS's initiative have been largely positive. Users have praised the modernization of services and emphasized the importance of incorporating digital tools into healthcare. While many acknowledged the institution's progress, some users also pointed out the necessity for the platform to undergo constant updates and a period of adaptation to ensure reliable information and meet the needs of the insured population.

DistantNews Editorial

Originally published by TVN Panamรก in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.